BIOVF Statistics
Total Valuation
BIOVF has a market cap or net worth of 10.64 billion. The enterprise value is 11.97 billion.
| Market Cap | 10.64B |
| Enterprise Value | 11.97B |
Important Dates
The next estimated earnings date is Wednesday, July 16, 2025.
| Earnings Date | Jul 16, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 343.46M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.71% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 219.69M |
Valuation Ratios
The trailing PE ratio is 26.96 and the forward PE ratio is 20.41.
| PE Ratio | 26.96 |
| Forward PE | 20.41 |
| PS Ratio | 4.07 |
| PB Ratio | 2.73 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.51 |
| P/OCF Ratio | 14.37 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.37, with an EV/FCF ratio of 16.33.
| EV / Earnings | 30.35 |
| EV / Sales | 4.44 |
| EV / EBITDA | 12.37 |
| EV / EBIT | 20.08 |
| EV / FCF | 16.33 |
Financial Position
The company has a current ratio of 0.98, with a Debt / Equity ratio of 0.36.
| Current Ratio | 0.98 |
| Quick Ratio | 0.65 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 1.49 |
| Debt / FCF | 1.91 |
| Interest Coverage | 4.96 |
Financial Efficiency
Return on equity (ROE) is 10.55% and return on invested capital (ROIC) is 6.71%.
| Return on Equity (ROE) | 10.55% |
| Return on Assets (ROA) | 5.02% |
| Return on Invested Capital (ROIC) | 6.71% |
| Return on Capital Employed (ROCE) | 9.98% |
| Revenue Per Employee | 1.38M |
| Profits Per Employee | 208,184 |
| Employee Count | 1,806 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.53 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.36% in the last 52 weeks. The beta is 0.26, so BIOVF's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | +33.36% |
| 50-Day Moving Average | 27.85 |
| 200-Day Moving Average | 23.28 |
| Relative Strength Index (RSI) | 58.42 |
| Average Volume (20 Days) | 408 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIOVF had revenue of 2.61 billion and earned 394.51 million in profits. Earnings per share was 1.14.
| Revenue | 2.61B |
| Gross Profit | 2.05B |
| Operating Income | 578.21M |
| Pretax Income | 450.40M |
| Net Income | 394.51M |
| EBITDA | 925.70M |
| EBIT | 578.21M |
| Earnings Per Share (EPS) | 1.14 |
Balance Sheet
The company has 99.32 million in cash and 1.40 billion in debt, giving a net cash position of -1.30 billion.
| Cash & Cash Equivalents | 99.32M |
| Total Debt | 1.40B |
| Net Cash | -1.30B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.89B |
| Book Value Per Share | 11.32 |
| Working Capital | -24.51M |
Cash Flow
In the last 12 months, operating cash flow was 739.90 million and capital expenditures -6.77 million, giving a free cash flow of 733.13 million.
| Operating Cash Flow | 739.90M |
| Capital Expenditures | -6.77M |
| Free Cash Flow | 733.13M |
| FCF Per Share | n/a |
Margins
Gross margin is 78.30%, with operating and profit margins of 22.12% and 15.09%.
| Gross Margin | 78.30% |
| Operating Margin | 22.12% |
| Pretax Margin | 17.23% |
| Profit Margin | 15.09% |
| EBITDA Margin | 35.42% |
| EBIT Margin | 22.12% |
| FCF Margin | 28.05% |
Dividends & Yields
BIOVF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.71% |
| Shareholder Yield | -2.71% |
| Earnings Yield | 3.71% |
| FCF Yield | 6.89% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIOVF has an Altman Z-Score of 3.08.
| Altman Z-Score | 3.08 |
| Piotroski F-Score | n/a |